213 related articles for article (PubMed ID: 30250467)
1. Increased Risk for Malignancies in 131 Affected
Egg D; Schwab C; Gabrysch A; Arkwright PD; Cheesman E; Giulino-Roth L; Neth O; Snapper S; Okada S; Moutschen M; Delvenne P; Pecher AC; Wolff D; Kim YJ; Seneviratne S; Kim KM; Kang JM; Ojaimi S; McLean C; Warnatz K; Seidl M; Grimbacher B
Front Immunol; 2018; 9():2012. PubMed ID: 30250467
[No Abstract] [Full Text] [Related]
2. Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects.
Schwab C; Gabrysch A; Olbrich P; Patiño V; Warnatz K; Wolff D; Hoshino A; Kobayashi M; Imai K; Takagi M; Dybedal I; Haddock JA; Sansom DM; Lucena JM; Seidl M; Schmitt-Graeff A; Reiser V; Emmerich F; Frede N; Bulashevska A; Salzer U; Schubert D; Hayakawa S; Okada S; Kanariou M; Kucuk ZY; Chapdelaine H; Petruzelkova L; Sumnik Z; Sediva A; Slatter M; Arkwright PD; Cant A; Lorenz HM; Giese T; Lougaris V; Plebani A; Price C; Sullivan KE; Moutschen M; Litzman J; Freiberger T; van de Veerdonk FL; Recher M; Albert MH; Hauck F; Seneviratne S; Pachlopnik Schmid J; Kolios A; Unglik G; Klemann C; Speckmann C; Ehl S; Leichtner A; Blumberg R; Franke A; Snapper S; Zeissig S; Cunningham-Rundles C; Giulino-Roth L; Elemento O; Dückers G; Niehues T; Fronkova E; Kanderová V; Platt CD; Chou J; Chatila TA; Geha R; McDermott E; Bunn S; Kurzai M; Schulz A; Alsina L; Casals F; Deyà-Martinez A; Hambleton S; Kanegane H; Taskén K; Neth O; Grimbacher B
J Allergy Clin Immunol; 2018 Dec; 142(6):1932-1946. PubMed ID: 29729943
[TBL] [Abstract][Full Text] [Related]
3. Do common infections trigger disease-onset or -severity in CTLA-4 insufficiency?
Krausz M; Mitsuiki N; Falcone V; Komp J; Posadas-Cantera S; Lorenz HM; Litzman J; Wolff D; Kanariou M; Heinkele A; Speckmann C; Häcker G; Hengel H; Gámez-Díaz L; Grimbacher B
Front Immunol; 2022; 13():1011646. PubMed ID: 36405723
[TBL] [Abstract][Full Text] [Related]
4. High frequencies of asymptomatic Epstein-Barr virus viremia in affected and unaffected individuals with CTLA4 mutations.
Hoshino A; Tanita K; Kanda K; Imadome KI; Shikama Y; Yasumi T; Imai K; Takagi M; Morio T; Kanegane H
Clin Immunol; 2018 Oct; 195():45-48. PubMed ID: 30048690
[TBL] [Abstract][Full Text] [Related]
5. A Patient with CTLA-4 Haploinsufficiency Presenting Gastric Cancer.
Hayakawa S; Okada S; Tsumura M; Sakata S; Ueno Y; Imai K; Morio T; Ohara O; Chayama K; Kobayashi M
J Clin Immunol; 2016 Jan; 36(1):28-32. PubMed ID: 26644313
[TBL] [Abstract][Full Text] [Related]
6. What did we learn from CTLA-4 insufficiency on the human immune system?
Mitsuiki N; Schwab C; Grimbacher B
Immunol Rev; 2019 Jan; 287(1):33-49. PubMed ID: 30565239
[TBL] [Abstract][Full Text] [Related]
7. Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations.
Schubert D; Bode C; Kenefeck R; Hou TZ; Wing JB; Kennedy A; Bulashevska A; Petersen BS; Schäffer AA; Grüning BA; Unger S; Frede N; Baumann U; Witte T; Schmidt RE; Dueckers G; Niehues T; Seneviratne S; Kanariou M; Speckmann C; Ehl S; Rensing-Ehl A; Warnatz K; Rakhmanov M; Thimme R; Hasselblatt P; Emmerich F; Cathomen T; Backofen R; Fisch P; Seidl M; May A; Schmitt-Graeff A; Ikemizu S; Salzer U; Franke A; Sakaguchi S; Walker LSK; Sansom DM; Grimbacher B
Nat Med; 2014 Dec; 20(12):1410-1416. PubMed ID: 25329329
[TBL] [Abstract][Full Text] [Related]
8. CTLA4 haploinsufficiency as a predisposition to classical Hodgkin lymphoma.
Mahat U; Terzioglu MK; Buhtoiarov I
Pediatr Hematol Oncol; 2020 Mar; 37(2):176-183. PubMed ID: 31971458
[TBL] [Abstract][Full Text] [Related]
9. A sporadic case of CTLA4 haploinsufficiency manifesting as Epstein-Barr virus-positive diffuse large B-cell lymphoma.
Yuan H; Nishikori M; Ueda C; Fujimoto M; Yasumi T; Otsuka Y; Kitawaki T; Hirata M; Haga H; Kanegane H; Takaori-Kondo A
J Clin Exp Hematop; 2022 Mar; 62(1):52-57. PubMed ID: 34707038
[TBL] [Abstract][Full Text] [Related]
10. Multifocal gastric adenocarcinoma in a patient with LRBA deficiency.
Bratanič N; Kovač J; Pohar K; Trebušak Podkrajšek K; Ihan A; Battelino T; Avbelj Stefanija M
Orphanet J Rare Dis; 2017 Jul; 12(1):131. PubMed ID: 28720148
[TBL] [Abstract][Full Text] [Related]
11. Immune dysregulation syndrome with de novo CTLA4 germline mutation responsive to abatacept therapy.
Ureshino H; Koarada S; Kamachi K; Yoshimura M; Yokoo M; Kubota Y; Ando T; Ichinohe T; Morio T; Kimura S
Int J Hematol; 2020 Jun; 111(6):897-902. PubMed ID: 31993940
[TBL] [Abstract][Full Text] [Related]
12. Heterozygous
Mahat U; Ambani NM; Rotz SJ; Radhakrishnan K
Pediatr Hematol Oncol; 2021 Oct; 38(7):658-662. PubMed ID: 33900894
[TBL] [Abstract][Full Text] [Related]
13. CTLA4 Message Reflects Pathway Disruption in Monogenic Disorders and Under Therapeutic Blockade.
Garcia-Perez JE; Baxter RM; Kong DS; Tobin R; McCarter M; Routes JM; Verbsky J; Jordan MB; Dutmer CM; Hsieh EWY
Front Immunol; 2019; 10():998. PubMed ID: 31156616
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic options for CTLA-4 insufficiency.
Egg D; Rump IC; Mitsuiki N; Rojas-Restrepo J; Maccari ME; Schwab C; Gabrysch A; Warnatz K; Goldacker S; Patiño V; Wolff D; Okada S; Hayakawa S; Shikama Y; Kanda K; Imai K; Sotomatsu M; Kuwashima M; Kamiya T; Morio T; Matsumoto K; Mori T; Yoshimoto Y; Dybedal I; Kanariou M; Kucuk ZY; Chapdelaine H; Petruzelkova L; Lorenz HM; Sullivan KE; Heimall J; Moutschen M; Litzman J; Recher M; Albert MH; Hauck F; Seneviratne S; Pachlopnik Schmid J; Kolios A; Unglik G; Klemann C; Snapper S; Giulino-Roth L; Svaton M; Platt CD; Hambleton S; Neth O; Gosse G; Reinsch S; Holzinger D; Kim YJ; Bakhtiar S; Atschekzei F; Schmidt R; Sogkas G; Chandrakasan S; Rae W; Derfalvi B; Marquart HV; Ozen A; Kiykim A; Karakoc-Aydiner E; Králíčková P; de Bree G; Kiritsi D; Seidel MG; Kobbe R; Dantzer J; Alsina L; Armangue T; Lougaris V; Agyeman P; Nyström S; Buchbinder D; Arkwright PD; Grimbacher B
J Allergy Clin Immunol; 2022 Feb; 149(2):736-746. PubMed ID: 34111452
[TBL] [Abstract][Full Text] [Related]
15. Relationship between PPP1R15A gene polymorphism (rs611251) and Epstein-Barr virus-associated tumors.
Song Y; Liu S; Zhao Z; Zhang Y; Yang Y; Luo B
Acta Virol; 2017; 61(4):445-452. PubMed ID: 29186961
[TBL] [Abstract][Full Text] [Related]
16. Investigation of Cytotoxic T-lymphocyte antigen 4 Polymorphisms in Gastric Cardia Adenocarcinoma.
Tang W; Wang Y; Chen S; Lin J; Chen B; Yu S; Chen Y; Gu H; Kang M
Scand J Immunol; 2016 Mar; 83(3):212-8. PubMed ID: 26709093
[TBL] [Abstract][Full Text] [Related]
17. Distribution of the Epstein-Barr virus in the normal stomach and gastric lesions in Thai population.
Wanvimonsuk S; Thitiwanichpiwong P; Keelawat S; Mutirangura A; Kitkumthorn N
J Med Virol; 2019 Mar; 91(3):444-449. PubMed ID: 30229949
[TBL] [Abstract][Full Text] [Related]
18. Elevated antibody titers to Epstein-Barr virus prior to the diagnosis of Epstein-Barr-virus-associated gastric adenocarcinoma.
Levine PH; Stemmermann G; Lennette ET; Hildesheim A; Shibata D; Nomura A
Int J Cancer; 1995 Mar; 60(5):642-4. PubMed ID: 7860138
[TBL] [Abstract][Full Text] [Related]
19. High prevalence of Epstein-Barr virus in gastric remnant carcinoma after Billroth-II reconstruction.
Nishikawa J; Yanai H; Hirano A; Okamoto T; Nakamura H; Matsusaki K; Kawano T; Miura O; Okita K
Scand J Gastroenterol; 2002 Jul; 37(7):825-9. PubMed ID: 12190097
[TBL] [Abstract][Full Text] [Related]
20. Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4.
Kuehn HS; Ouyang W; Lo B; Deenick EK; Niemela JE; Avery DT; Schickel JN; Tran DQ; Stoddard J; Zhang Y; Frucht DM; Dumitriu B; Scheinberg P; Folio LR; Frein CA; Price S; Koh C; Heller T; Seroogy CM; Huttenlocher A; Rao VK; Su HC; Kleiner D; Notarangelo LD; Rampertaap Y; Olivier KN; McElwee J; Hughes J; Pittaluga S; Oliveira JB; Meffre E; Fleisher TA; Holland SM; Lenardo MJ; Tangye SG; Uzel G
Science; 2014 Sep; 345(6204):1623-1627. PubMed ID: 25213377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
